Kronos Bio, Inc.
NASDAQ:KRON
0.9476 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 64.326 | 75.973 | 339.509 | 462.062 | 32.57 | 10.226 |
| Short Term Investments
| 108.671 | 162.212 | 141.239 | 165.052 | 59.614 | 0 |
| Cash and Short Term Investments
| 172.997 | 247.947 | 339.509 | 462.062 | 92.184 | 10.226 |
| Net Receivables
| 0 | 0.572 | 0.816 | 0.612 | 0.198 | 0 |
| Inventory
| 0 | -10.334 | -0.816 | -49.613 | -0.198 | 0 |
| Other Current Assets
| 5.781 | 6.106 | 8.045 | 6.741 | 1.119 | 0.315 |
| Total Current Assets
| 178.778 | 244.291 | 347.554 | 419.802 | 93.303 | 10.541 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 29.909 | 37.692 | 41.784 | 40.968 | 4.194 | 1.8 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 4.015 | 9.762 | 2.026 | 49.001 | 4.762 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.577 | 3.193 | 0.112 | 2.193 | 0.427 | 0.273 |
| Total Non-Current Assets
| 34.501 | 50.647 | 43.922 | 92.162 | 9.383 | 2.073 |
| Total Assets
| 213.279 | 294.938 | 391.476 | 511.964 | 102.686 | 12.614 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0.883 | 5.047 | 0.998 | 4.55 | 1.506 | 0.777 |
| Short Term Debt
| 2.893 | 2.347 | 2.109 | 0.942 | 0.317 | 0.278 |
| Tax Payables
| 0.133 | 0.04 | 0 | 0.558 | 0.043 | 0.009 |
| Deferred Revenue
| 9.584 | 0 | 9.063 | 4.974 | 0.818 | 0.009 |
| Other Current Liabilities
| 11.335 | 14.092 | 1.456 | 2.39 | 0.056 | 0.247 |
| Total Current Liabilities
| 24.695 | 21.486 | 13.626 | 12.856 | 2.697 | 1.311 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 25.379 | 28.744 | 31.653 | 31.12 | 0.211 | 0.493 |
| Deferred Revenue Non-Current
| 4.127 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| -4.127 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 4.127 | 0.209 | 1.1 | 2.469 | 122.981 | 18.106 |
| Total Non-Current Liabilities
| 29.506 | 28.953 | 32.753 | 33.589 | 123.192 | 18.599 |
| Total Liabilities
| 54.201 | 50.439 | 46.379 | 46.445 | 125.889 | 19.91 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 511.964 | 122.907 | 17.985 |
| Common Stock
| 0.059 | 0.057 | 0.056 | 0.054 | 0.006 | 0.005 |
| Retained Earnings
| -508.861 | -396.188 | -262.984 | -111.906 | -23.462 | -7.345 |
| Accumulated Other Comprehensive Income/Loss
| 0.019 | -0.792 | -0.039 | -0.019 | -0.018 | -17.985 |
| Other Total Stockholders Equity
| 667.861 | 641.422 | 608.064 | 65.426 | -122.636 | 0.044 |
| Total Shareholders Equity
| 159.078 | 244.499 | 345.097 | 465.519 | -23.203 | -7.296 |
| Total Equity
| 159.078 | 244.499 | 345.097 | 465.519 | -23.203 | -7.296 |
| Total Liabilities & Shareholders Equity
| 213.279 | 294.938 | 391.476 | 511.964 | 102.686 | 12.614 |